RE:RE:RE:RE:MCNA not officially dead yet"NovaVive is a private company founded in July, 2014. The Company acquired an advanced veterinary immunotherapeutic platform based on mycobacterium cell wall fraction (MCWF) technology with four regulator-approved products. The MCWF platform was formerly part of Bioniche Animal Health. NovaVive also acquired the global license to MCNA for treating animal cancers."
https://novavive.ca/article/novavive-inc-summarizes-canine-cancer-data-presented-at-world-veterinary-cancer-congress